Evidence map›Paper›PMID 34452210›Full record

ArticlePharmaceutics2021

Magnetoliposomes Based on Shape Anisotropic Calcium/Magnesium Ferrite Nanoparticles as Nanocarriers for Doxorubicin.

Beatriz D Cardoso, Ana Rita O Rodrigues, Manuel Bañobre-López, Bernardo G Almeida, Carlos O Amorim, Vítor S Amaral, Paulo J G Coutinho, Elisabete M S Castanheira

Open access · goldAbstract read
In one paragraph

Article in Pharmaceutics, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
1.6field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 29 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Beatriz D CardosoPhysics Centre of Minho and Porto Universities (CF-UM-UP), Campus de Gualtar, 4710-057 Braga, Portugal.
Ana Rita O RodriguesPhysics Centre of Minho and Porto Universities (CF-UM-UP), Campus de Gualtar, 4710-057 Braga, Portugal.ORCID 0000-0002-6094-1713
Manuel Bañobre-LópezLife Sciences Department, INL-International Iberian Nanotechnology Laboratory, 4715-330 Braga, Portugal.ORCID 0000-0003-4319-2631
Bernardo G AlmeidaPhysics Centre of Minho and Porto Universities (CF-UM-UP), Campus de Gualtar, 4710-057 Braga, Portugal.
Carlos O AmorimPhysics Department and CICECO, University of Aveiro, 3810-193 Aveiro, Portugal.ORCID 0000-0003-4148-4374
Vítor S AmaralPhysics Department and CICECO, University of Aveiro, 3810-193 Aveiro, Portugal.
Paulo J G CoutinhoPhysics Centre of Minho and Porto Universities (CF-UM-UP), Campus de Gualtar, 4710-057 Braga, Portugal.ORCID 0000-0003-4426-9207
Elisabete M S CastanheiraPhysics Centre of Minho and Porto Universities (CF-UM-UP), Campus de Gualtar, 4710-057 Braga, Portugal.ORCID 0000-0002-5829-6081
University of Minho · PTUniversity of Aveiro · PTInternational Iberian Nanotechnology Laboratory · PT

Funding

European Regional Development Fund POCI-01-0145-FEDER-028020Fundação para a Ciência e a Tecnologia PTDC/QUI-QFI/28020/2017Fundação para a Ciência e a Tecnologia SFRH/BD/141936/2018Fundação para a Ciência e a Tecnologia UIDB/04650/2020Programa Operacional Temático Factores de Competitividade POCI-01-0145-FEDER-028020
6 · The paper itself

Abstract

Multifunctional lipid nanocarriers are a promising therapeutic approach for controlled drug release in cancer therapy. Combining the widely used liposome structure with magnetic nanoparticles in magnetoliposomes allies, the advantages of using liposomes include the possibility to magnetically guide, selectively accumulate, and magnetically control the release of drugs on target. The effectiveness of these nanosystems is intrinsically related to the individual characteristics of the two main components-lipid formulation and magnetic nanoparticles-and their physicochemical combination. Herein, shape-anisotropic calcium-substituted magnesium ferrite nanoparticles (Ca

Indexed as

doxorubicinmagnetic hyperthermiamagnetic nanoparticlesmagnetoliposomesmixed ferritesshape-anisotropy

Identifiers

PMID34452210
PMCPMC8401618
OpenAlexW3188482154

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.